C. Julié

发表

Hashimoto's thyroiditis associated with Riedel's thyroiditis and retroperitoneal fibrosis.

B. Franc, A. Vieillefond, G. Schaison, 1997, Pathology, research and practice.

Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks

H. Kestler, D. Aust, P. Lichter, 2007, BMC Cancer.

Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors.

P. Terrier, A. Barrier, A. Le Cesne, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.

N. Halama, H. Grabsch, D. Aust, 2016, European journal of cancer.

Immunotherapy revolutionises non-small-cell lung cancer therapy: Results, perspectives and new challenges.

T. Chinet, V. Giraud, S. Labrune, 2017, European journal of cancer.

KIT overexpression and amplification in gastrointestinal stromal tumors (GISTs).

M. Debiec‐Rychter, J. Emile, A. Wozniak, 2005, Biochimica et biophysica acta.

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

J. Emile, T. Chinet, A. Costantini, 2018, Oncoimmunology.

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer

H. Blons, J. Emile, T. Chinet, 2018, Oncoimmunology.

High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors

J. Emile, E. Giroux-Leprieur, A. Costantini, 2021, Frontiers in Oncology.

Endocervicosis of the urinary bladder. Immunohistochemical comparative study between a new case and normal uterine endocervices.

B. Franc, F. Staroz, A. Régnier, 2002, Pathology, research and practice.

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression

J. Emile, S. Garinet, T. Chinet, 2020, Journal for immunotherapy of cancer.

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials

D. Sargent, P. Laurent-Puig, R. Goldberg, 2017, JAMA oncology.

Association of IL-36γ with tertiary lymphoid structures and inflammatory immune infiltrates in human colorectal cancer

C. Sautès-Fridman, F. Petitprez, W. Fridman, 2018, Cancer Immunology, Immunotherapy.

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.

R. Salazar, P. Laurent-Puig, E. Van Cutsem, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors: A National Study from the French Group of Endocrine Tumors (GTE).

A. Tabarin, E. Baudin, V. Rohmer, 2019, Annals of surgery.

Validity of Targeted Next-Generation Sequencing in Routine Care for Identifying Clinically Relevant Molecular Profiles in Non-Small-Cell Lung Cancer: Results of a 2-Year Experience on 1343 Samples.

P. Laurent-Puig, B. Rance, H. Blons, 2018, The Journal of molecular diagnostics : JMD.

Analysis of DNA mismatch repair (MMR) and clinical outcome in stage III colon cancers from patients (pts) treated with adjuvant FOLFOX +/- cetuximab in the PETACC8 and NCCTG N0147 adjuvant trials.

D. Sargent, P. Laurent-Puig, R. Goldberg, 2015 .

Identification in Daily Practice of Patients With Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Revised Bethesda Guidelines-Based Approach Versus Molecular Screening

F. Radvanyi, P. Laurent-Puig, B. Nordlinger, 2008, The American Journal of Gastroenterology.

Multidrug Resistance Proteins in Gastrointestinal Stromal Tumors: Site-Dependent Expression and Initial Response to Imatinib

A. Le Cesne, J. Emile, R. Farinotti, 2005, Clinical Cancer Research.

Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial.

P. Laurent-Puig, J. Tabernero, C. Lepage, 2016, JAMA oncology.

Complete calcification of colorectal liver metastases on imaging after chemotherapy does not indicate sterilization of disease.

B. Nordlinger, C. Penna, S. Benoist, 2012, Journal of visceral surgery.

Detection of BRAF p.V600E Mutations in Melanoma by Immunohistochemistry Has a Good Interobserver Reproducibility.

A. von Deimling, D. Capper, J. Emile, 2014, Archives of pathology & laboratory medicine.

Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases

B. Nordlinger, M. Mauer, M. D'Angelica, 2021, The journal of pathology. Clinical research.

Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.

D. Aust, P. Schlag, E. Tanis, 2015, European journal of cancer.

Linear quantification of lymphoid infiltration of the tumor margin: a reproducible method, developed with colorectal cancer tissues, for assessing a highly variable prognostic factor

B. Nordlinger, J. Emile, A. Beauchet, 2012, Diagnostic Pathology.

A model of primary culture of colorectal cancer and liver metastasis to predict chemosensitivity.

B. Nordlinger, A. Beauchet, C. Penna, 2011, The Journal of surgical research.

Rational testing for gene fusion in colorectal cancer: MSI and RAS-BRAF wild-type metastatic colorectal cancer as target population for systematic screening.

Y. Allory, S. Vacher, I. Bièche, 2022, European journal of cancer.

Evidence of heterogeneity within colorectal liver metastases for allelic losses, mRNA level expression and in vitro response to chemotherapeutic agents

P. Laurent-Puig, N. Goasguen, C. Penna, 2009, International journal of cancer.

The Ratio of Metastatic to Examined Lymph Nodes Is a Powerful Independent Prognostic Factor in Rectal Cancer

B. Nordlinger, P. Rougier, A. Beauchet, 2008, Annals of surgery.

Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

Catherine Julié, Mostafa El Hajjam, Antoine Brouquet, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Revisiting immune escape in colorectal cancer in the era of immunotherapy

Marieke E. Ijsselsteijn, H. Morreau, C. Sautès-Fridman, 2019, British Journal of Cancer.

Contribution of genetic amplification by PCR for the diagnosis of Helicobacter pylori infection in patients receiving proton pump inhibitors

J. Emile, J. Raymond, D. Lamarque, 2018, United European gastroenterology journal.

High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors.

A. Le Cesne, B. Debuire, J. Emile, 2004, Biochimica et biophysica acta.

Molecular characterization of circulating tumor cells in lung cancer: moving beyond enumeration

J. Emile, T. Chinet, B. He, 2017, Oncotarget.

CARMN‐NOTCH2 fusion transcript drives high NOTCH2 expression in glomus tumors of the upper digestive tract

N. Girard, J. Coindre, J. Emile, 2021, Genes, chromosomes & cancer.

Early Fat Embolism After Liposuction

F. Jardin, B. Page, T. Fourme, 1999 .

Early fat embolism after liposuction.

F. Jardin, B. Page, A. Vieillard-Baron, 1998, Anesthesiology.

Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer

J. Emile, T. Chinet, A. Costantini, 2021, Cancers.

Prolonged survival after resection of pancreatoblastoma and synchronous liver metastases in an adult.

B. Nordlinger, P. Rougier, C. Penna, 2001, Hepato-gastroenterology.

Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma.

P. Balladur, M. Resche-Rigon, J. Bachet, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation.

S. Imbeaud, J. Zucman‐Rossi, P. Laurent-Puig, 2012, Journal of hepatology.

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab

J. Emile, T. Chinet, V. Giraud, 2019, Journal of Immunotherapy for Cancer.

Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer

V. Boige, C. Penna, T. Lazure, 2017, Annals of Surgical Oncology.

Pathological response of locally advanced rectal cancer to preoperative chemotherapy without pelvic irradiation

B. Nordlinger, C. Penna, T. Lazure, 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome

F. Radvanyi, P. Laurent-Puig, B. Nordlinger, 2012, International journal of cancer.

Salvage colectomy for endoscopically removed malignant colon polyps: is it possible to determine the optimal number of lymph nodes that need to be harvested?

B. Nordlinger, L. Benhaim, J. Bachet, 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Management of patients over 80 years of age treated with resection for localised colon cancer: results from a French referral centre.

A. Lièvre, B. Nordlinger, P. Rougier, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

J. Emile, T. Chinet, A. Costantini, 2020, Cancers.

Optimal oncologic treatment of rectal cancer in patients over 75 years old: Results of a strategy based on oncogeriatric evaluation.

A. Beauchet, T. Cudennec, D. Moszkowicz, 2018, Journal of visceral surgery.

Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials.

D. Sargent, P. Laurent-Puig, R. Goldberg, 2020, JCO precision oncology.

Accuracy of Magnetic Resonance Imaging in Rectal Cancer Depends on Location of the Tumor

B. Nordlinger, N. Siauve, A. Beauchet, 2005, Diseases of the colon and rectum.

Presentation and prognosis of local recurrence after total mesorectal excision

B. Nordlinger, A. Beauchet, C. Penna, 2009, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Radiofrequency ablation for colorectal cancer liver metastases initially greater than 25 mm but downsized by neo-adjuvant chemotherapy is associated with increased rate of local tumor progression.

B. Nordlinger, L. Benhaim, A. Beauchet, 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer.

L. Collette, D. Aust, E. Van Cutsem, 2008, European journal of cancer.

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer (NSCLC) treated with nivolumab (nivo).

J. Emile, T. Chinet, E. Giroux-Leprieur, 2018, Lung Cancer.

Second- and third-line chemotherapy in patients with metastatic pancreatic adenocarcinoma: feasibility and potential benefits in a retrospective series of 117 patients.

A. Lièvre, P. Rougier, J. Emile, 2009, Gastroentérologie Clinique et Biologique.

Chemotherapy as initial treatment of locally advanced unresectable pancreatic cancer: a valid option?

B. Nordlinger, M. Housset, P. Rougier, 2007, Gastroenterologie clinique et biologique.

709PD FIVE-YEAR RESULTS OF THE RANDOMIZED PHASE III TRIAL COMPARING S-1 MONOTHERAPY VERSUS SURGERY ALONE FOR STAGE II/III GASTRIC CANCER PATIENTS AFTER CURATIVE D2 GASTRECTOMY (ACTS-GC STUDY)

M. Romano, B. Nordlinger, F. Zhang, 2010 .

Patients and methods Patients and samples Between 1998 and 2009 , 244 patients underwent hepatic resection for colorectal liver metastasis at the Ambroise Paré Hospital

S. Imbeaud, J. Zucman‐Rossi, P. Laurent-Puig, 2012 .

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX.

P. Laurent-Puig, F. Penault-Llorca, J. Tabernero, 2017, European journal of cancer.

Revisiting immune escape in colorectal cancer in the era of immunotherapy

Marieke E. Ijsselsteijn, H. Morreau, C. Sautès-Fridman, 2019, British Journal of Cancer.

Risk factors for chemotherapy-associated liver injuries: A multivariate analysis of a group of 146 patients with colorectal metastases.

B. Nordlinger, P. Rougier, A. Beauchet, 2009, Surgery.

Multicenter validation study of pathologic response and tumor thickness at the tumor‐normal liver interface as independent predictors of disease‐free survival after preoperative chemotherapy and surgery for colorectal liver metastases

J. Vauthey, B. Nordlinger, T. Gruenberger, 2013, Cancer.

Impact of Chemotherapy on the Accuracy of Computed Tomography Scan for the Evaluation of Colorectal Liver Metastases

B. Nordlinger, P. Rougier, A. Beauchet, 2009, Annals of Surgical Oncology.

Portal triad clamping (TC) or hepatic vascular exclusion (VE) for major liver resection after prolonged neoadjuvant chemotherapy? A case-matched study in 60 patients.

B. Nordlinger, P. Rougier, C. Penna, 2006, Surgery.

Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases

J. Thiery, C. Boulard, F. Radvanyi, 2004, British Journal of Cancer.

Validation of the prognostic impact of lymphocyte infiltration (LI) in patients (pts) with stage III colon cancer (CC) treated with adjuvant FOLFOX+/- cetuximab: A PETACC8 translational study.

P. Laurent-Puig, J. Tabernero, C. Lepage, 2016 .

Total mesorectal excision for cancer: histological and immunohistochemical evidence of nerve removal and risk‐factor analysis

B. Nordlinger, A. Beauchet, K. Nyangoh Timoh, 2016, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab

J. Emile, A. Costantini, V. Giraud, 2022, Cancer Immunology, Immunotherapy.

Multispectral imaging detects gastritis consistently in mouse model and in humans

F. Goudail, J. Emile, M. Boffety, 2020, Scientific Reports.

MRI Apparent Diffusion Coefficient (ADC) as a Biomarker of Tumour Response: Imaging-Pathology Correlation in Patients with Hepatic Metastases from Colorectal Cancer (EORTC 1423)

A. Jackson, J. Theysohn, S. Litière, 2023, Cancers.

Cutaneous Perianal Recurrence on the Site of Lone Star Retractor™ after J-pouch Coloanal Anastomosis for Rectal Cancer: Report of Two Cases

B. Nordlinger, P. Rougier, C. Penna, 2008, Diseases of the colon and rectum.

[Imaging features of gastric stromal tumors: radiologic-pathologic correlation. Report of 4 cases].

A. Luciani, P. Lacombe, S. Qanadli, 2000, Journal de radiologie.

Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.

D. Aust, P. Schlag, E. Tanis, 2015, European journal of cancer.

Complete radiological response of colorectal liver metastases (LM) after chemotherapy: Does it mean cure?

B. Nordlinger, P. Rougier, S. Chagnon, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can We Predict Complete or Major Response after Chemoradiotherapy for Rectal Cancer by Noninvasive Methods? Results of a Prospective Study on 61 Patients

B. Nordlinger, A. Beauchet, C. Penna, 2014, The American surgeon.

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX.

P. Laurent-Puig, F. Penault-Llorca, J. Tabernero, 2017, European journal of cancer.